Zoetis Inc (ZTS)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $34.29B
Last updated: Nov 17, 2026 at 4:59 PM ET
Zoetis Inc (ZTS) Stock Chart
Zoetis (ZTS) has a latest price of $83.47 on Nov 17, 2026, 35.8% below its 52-week high of $130.12. Its price fell 29.8% over the past 12 months. The month-end price rose 66.8% over the 10 years through Oct 2026, a compound annual rate of 5.2%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $244.03 in Dec 2021 and its lowest $47.80 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ZTS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ZTS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 9.6%, and over 6 months it rose 6.5%. The month-end price fell 49.2% over the 3 years through Oct 2026, a compound annual decline of 20.2%.
| Period | Change |
|---|---|
| 1 month | +5.6% |
| 3 months | +9.6% |
| 6 months | +6.5% |
| 12 months | -29.8% |
| 12 months, with dividends | -28.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -49.2% | -20.2% |
| 5 years | -63.1% | -18.1% |
| 10 years | +66.8% | +5.2% |
Price by Year
Its best calendar year was 2019, when the price rose 54.7%, and its weakest was 2022, when it fell 39.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $79.72 | -36.6% |
| 2025 | $125.82 | -22.8% |
| 2024 | $162.93 | -17.4% |
| 2023 | $197.37 | +34.7% |
| 2022 | $146.55 | -39.9% |
| 2021 | $244.03 | +47.5% |
| 2020 | $165.50 | +25.0% |
| 2019 | $132.35 | +54.7% |
| 2018 | $85.54 | +18.7% |
| 2017 | $72.04 | +34.6% |
Trading Range
The price is 9.4% above its 50-day average of $76.30 and 7.5% below its 200-day average of $90.29.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $83.47 | |
| 52-week high | $130.12 | -35.8% |
| 52-week low | $68.31 | +22.2% |
| 50-day average | $76.30 | +9.4% |
| 200-day average | $90.29 | -7.5% |
Price Risk
Over 3 years, its largest fall from a peak was 64.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.60 |
| Largest fall, 1 year | -47.0% |
| Largest fall, 3 years | -64.4% |
Valuation
Zoetis traded at 19.6x earnings at the end of 2025, against a 5-year median of 31.4x and a 10-year median of 31.9x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ZTS
What is ZTS's 1-year price change?
Zoetis's price fell 29.8% over the past 12 months. With dividends included, the 12-month total return was -28.0%.
What is ZTS's 5-year price change?
Zoetis's month-end price fell 63.1% over the 5 years through Oct 2026, a compound annual decline of 18.1%. These figures leave out dividends.
What is ZTS's 52-week high and low?
Zoetis's 52-week high is $130.12 and its 52-week low is $68.31. Its latest price of $83.47 on Nov 17, 2026 is 35.8% below the high.
What is ZTS's beta?
Zoetis's 1-year beta against the S&P 500 is 0.60, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 47.0%.
Is the ZTS chart free?
Yes. Advanced Charting for ZTS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ZTS pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts